Clinical Trials Sponsored by Deling Li

Total 4442 results

Yong Li

Completed

Effect of Organic Naked Oat With Whole Germ on Type 2 Diabetes Mellitus

Diabetes Mellitus

China
Li-jun Ding

Recruiting

Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency

Premature Ovarian Insufficiency

China
Junling Li

Unknown

The Efficacy and Safety of Apatinib Monotherapy in Maintenance Treatment of Extensive-stage Small-cell Lung Cancer

Apatinib in Maintenance Treatment

China
Xuesong Li

Unknown

Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas

Upper Tract Urothelial Carcinoma | Bladder Recurrence
Zheng Li

Not yet recruiting

Trajectory of Frailty and Cognitive Dysfunction in Older Adults

Cognitive Dysfunction | Frailty | Community-dwelling Older Adults
Xuesong Li

Recruiting

Combined Postoperative Radiotherapy With Kidney Sparing Surgery for Locally Advanced High-risk Ureteral Cancer

Urothelial Carcinoma Ureter | Locally Advanced

China
Peking University Third Hospital
Yunfeng Li

Not yet recruiting

Bioglass Wound Dressing in Treatment of Chronic Wound in Different Stage：a Randomized Controlled Trial

Chronic Wound
Junling Li

Recruiting

Camrelizumab Plus Apatinib for Advanced Non-Squamous NSCLC Previously Treated With First-Line Immunotherapy

Advanced Non Squamous NSCLC

China
Junling Li

Unknown

Efficacy and Safety of IBI308 and Paclitaxel/Albumin Paclitaxel for SCLC Patients Who Failed Etoposide Chemotherapy

Extensive-Stage Small Cell Lung Cancer

China
LI Taisheng

Completed

Safety and Efficacy Study of TwHF in HIV Patients With Poor Immune Responses

HIV

China
LI Taisheng

Unknown

Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders (CACTrip12)

HIV

China
Li-jun Ding

Unknown

Select Embryos by Time-lapse System for Single Embryo Transfer (SETLSSET)

Embryo
Li-jun Ding

Completed

Effects of UCA-PSCs in Women With POF

Premature Ovarian Failure

China
Li-jun Ding

Unknown

To Study the Effect of Magnetic Activated Sperm Sorting on the Outcome of in Vitro Fertilization-embryo Transplantation (MASS)

Infertility, Male

China
Li Huiping

Not yet recruiting

A Multicenter Clinical Study of Apatinib Mesylate Combined With Doctor's Choice for Advanced Breast Cancer

Advanced Breast Cancer
Lei Li

Recruiting

ctDNA Methylation for Detecting Ovarian Cancer

Epithelial Ovarian Cancer | Circulating Tumor DNA | CA125 | DNA Methylation | Non-invasive Diagnosis | Human Epididymis Protein 4 | Imaging Evaluation | Survival Prognosis | ROMA Index

China
Lei Li

Recruiting

Niraparib Plus Anlotinib for Recurrent Ovarian Cancer

Chemotherapy | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Niraparib | Anlotinib | CA125 | Targeted Therapy | Recurrent Ovarian Cancer

China
Lei Li

Recruiting

PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer

Cervical Carcinoma | Immunotherapy | Survival Outcomes | Adverse Events | Locally Advanced Cervical Cancer | Chemoradiotherapy | Immune Checkpoint Inhibitor | Anti-programmed Cell Death Receptor 1 | Early Stage Cervical Cancer

China
Lei Li

Recruiting

Prognosis of Low-grade Endometrial Stromal Sarcoma

Recurrence | Survival Outcomes | Adjuvant Therapy | Hormone Therapy | Low Grade Endometrial Stromal Sarcoma of Uterus (Diagnosis) | Fertility-sparing Surgery | Fertility Outcomes

China
Lei Li

Recruiting

Tislelizumab and Radiotherapy for Recurrent Cervical Cancer

Recurrent Cervical Carcinoma | Radiotherapy | Immunotherapy | Survival Outcomes | Immune Checkpoint Inhibitors | Objective Response Rate | Metastatic Cervical Carcinoma | Tislelizumab | Persistent Cervical Carcinoma | Anti-programmed Cell Death Receptor 1

China
Lei Li

Recruiting

Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial

Chemotherapy | Recurrent Cervical Carcinoma | Immune Checkpoint Inhibitors | Anti-PD-1 Antibody | Persistent Advanced Cervical Carcinoma | Albumin-bound Paclitaxel

China
Lei Li

Recruiting

Genetic Mutation in Recurrent Cervical Cancer

Microsatellite Instability | Recurrent Cervical Cancer | PD-L1 | Nucleotide Variant | Copy Number Variation | Insertion-deletion Variation | Genomic Structural Variation | Total Mutation Burden | PD-1

China
Lei Li

Recruiting

Survival Outcomes of Uterine Malignancies in Chinese Population

Endometrial Neoplasms | Survival

China
Lei Li

Unknown

A Training Set for the HRD Model in EOC

Epithelial Ovarian Cancer | Homologous Recombination Deficiency | Prognosis | BRCA Mutation | Loss of Heterozygosity | Platinum Resistance

China
Lei Li

Unknown

Immunohistochemical Staining of p16 for the Screening of Cervical Cancer

Cervical Intraepithelial Neoplasia | Cervical Cancer Screening | Histology | p16 Protein | Cytology | High-risk Human Papillomavirus | Diagnostic Accuracy

China
Lei Li

Unknown

Cell-free DNA Methylation for Epithelial Ovarian Cancer

Epithelial Ovarian Cancer | Liquid Biopsy | DNA Methylation | Benign Ovarian Tumor | Training Set | Validation Set | Cell-free DNA

China
Lei Li

Unknown

Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas

Chemotherapy | Recurrent Cervical Carcinoma | Adverse Drug Event | Cervical Neuroendocrine Carcinoma | Objective Response Rate | Advanced Cervical Carcinoma | Anti-pd-1 Antibody

China
Lei Li

Unknown

Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer

Epithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Homologous Recombination Deficiency | Prognosis | Chinese

China
Lei Li

Unknown

Multi-omics Study on the Pathogenesis of Malignant Transformation of Adenomyosis

Endometrial Cancer | Adenomyosis | Genomics | Eutopic Endometrium | Transcriptomics | Ectopic Endometrial Tissue

China
Rongrong Li

Unknown

The Correlation Between Iodine and Selenium Status in Pregnancy and Risk of Thyroid Disease

Iodine Excess in Pregnancy | Selenium Excess in Pregnancy | Iodine Deficiency in Pregnancy | Selenium Deficiency in Pregnancy
Lei Li

Unknown

A Multi-omics Study of Epithelial Ovarian Cancer

Epithelial Ovarian Cancer | Metabolomics | Transcriptomics | Whole Exome Sequencing | Tumor Invasiveness | Tumorigenesis

China
Lei Li

Unknown

Survival Outcomes of Ovarian Malignancies in Chinese Population

Ovarian Neoplasms | Survival

China
Lei Li

Unknown

Survival Outcomes of Uterine Cervical Malignancies in Chinese Population

Uterine Cervical Neoplasms | Survival

China
Lei Li

Recruiting

HRD and Resistance to PAPPi in EOC Patients

Epithelial Ovarian Cancer | Homologous Recombination Deficiency | Homologous Recombination Repair Gene Mutation | Drug Resistance | Overall Survival | Progression-free Survival | Poly(ADP-ribose) Polymerase Inhibitor

China
Lei Li

Recruiting

Cervical Cancer Screening Strategies

Cervical Cancer | Cervical Intraepithelial Neoplasia | Human Papillomavirus Infection | Cancer Screening | Cervical Cytology

China
Lei Li

Recruiting

Different Surgical Approaches in Patients of Early-stage Cervical Cancer

Quality of Life | Mortality | Pelvic Floor Disorders | Laparotomy | Laparoscopy | Cost-Benefit Analysis | Morbidity | Survival | Uterine Cervical Neoplasm

China
Lei Li

Recruiting

Longitudinal Study of Different Surgical Approaches in Chinese Patients of Uterine Cervical Cancer

Recurrence | Uterine Cervical Neoplasms | Mortality | Laparotomy | Laparoscopy | Survival

China
Lei Li

Completed

Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy

Chemotherapy | Recurrent Cervical Carcinoma | Immunotherapy | Anti-PD-1 Antibody | Persistent Advanced Cervical Carcinoma

China
Lei Li

Completed

First-line Chemotherapy for Recurrent Cervical Cancer

Chemotherapy | Recurrent Cervical Carcinoma | Apatinib | Targeted Therapy | Persistent Advanced Cervical Carcinoma | Vascular Endothelial Growth Factor 2 Inhibitor

China
Lei Li

Unknown

DNA Methylation Testing for the Screening of Uterine Cervical Lesion

Cervical Cancer | Cervical Intraepithelial Neoplasia | DNA Methylation | Cytology | High-risk Human Papillomavirus

China
Lei Li

Unknown

National Survey of Workplace Violence (CMDA-SURVEY1)

Questionnaire | China | Workplace Violence Against Physicians | National Survey | Obstetrics and Gynecology | Random Sample

China
Lei Li

Unknown

A Cohort Study for the Following up of Conization

Pregnancy | Fertility | Precancerous Lesions | Human Papillomavirus Infection | Uterine Cervical Cancer | High Grade Intraepithelial Neoplasia | Conization

China
Lei Li

Unknown

G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients

Gynecologic Cancer | Febrile Neutropenia | Chemotherapy-induced Neutropenia | Myelosuppression Adult

China
Lei Li

Unknown

MSI in Circulatory DNA of Endometrial Cancer

Lynch Syndrome | Endometrial Cancer | Microsatellite Instability | Circulating Tumor Cell

China
Jun Li

Unknown

One Dose Versus Three Weekly Doses of Benzathine Penicillin G for Patients With Early Syphilis

Syphilis

China
Lei Li

Unknown

A Multi-omics Study of Adenomyosis

Endometriosis | Adenomyosis | Genomics | Metabolomics | Ectopic Endometrium | Eutopic Endometrium | Transcriptomics

China
Lei Li

Unknown

Non-coding RNA in the Exosome of the Epithelia Ovarian Cancer

Ovarian Cancer | High Grade Serous Carcinoma | Prognosis | Early Diagnosis | Exosomes

China
Lei Li

Recruiting

ctDNA Methylation for Epithelial Ovarian Cancer

Epithelial Ovarian Cancer | Circulating Tumor DNA | CA125 | DNA Methylation | Non-invasive Diagnosis | Human Epididymis Protein 4 | Imaging Evaluation | Survival Prognosis

China
Lei Li

Recruiting

PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer

Recurrent Cervical Carcinoma | Radiotherapy | Immune Checkpoint Inhibitors | Overall Survival | Anti-programmed Death-1 Antibody | Metastatic Cervical Carcinoma | Persistent Advanced Cervical Carcinoma | Objective Remission Rate | Progression-free Survival | Severe Adverse Events

China
Lei Li

Recruiting

Albumin-bound Paclitaxel and Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer

Recurrent Ovarian Carcinoma | Platinum-resistant Ovarian Cancer | Bevacizumab | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Albumin-bound Paclitaxel

China

Clinical Trials Sponsored by Deling Li

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations